Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.
The report details the trend, potential and market size of Multiple Myeloma Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Multiple Myeloma Therapeuticsmarket, defines the market attractiveness level of Multiple Myeloma Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Multiple Myeloma Therapeutics industry, describes the types of Multiple Myeloma Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Multiple Myeloma Therapeutics market and the development prospects and opportunities of Multiple Myeloma Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Multiple Myeloma Therapeutics market in Chapter 13.
By Player:
Bristol-Myers Squibb Company
Bristol-Myers Squibb
Janssen Biotech Inc
Millennium Pharmaceuticals
Celgene Corporation
Juno Therapeutics
Kesios Therapeutics Limited
Amgene Inc
Novartis AG
Genzyme Corporation
By Type:
Chemotherapy and Other Drugs
Radiation
Stem Cell Transplant
Other Supportive Treatments
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Multiple Myeloma Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Multiple Myeloma Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Multiple Myeloma Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Multiple Myeloma Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Multiple Myeloma Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Multiple Myeloma Therapeutics Consumption (2017-2022)
-
7.2 United States Multiple Myeloma Therapeutics Consumption (2017-2022)
-
7.3 Europe Multiple Myeloma Therapeutics Consumption (2017-2022)
-
7.4 China Multiple Myeloma Therapeutics Consumption (2017-2022)
-
7.5 Japan Multiple Myeloma Therapeutics Consumption (2017-2022)
-
7.6 India Multiple Myeloma Therapeutics Consumption (2017-2022)
-
7.7 South Korea Multiple Myeloma Therapeutics Consumption (2017-2022)
8 Region and Country-wise Multiple Myeloma Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Multiple Myeloma Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Multiple Myeloma Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Multiple Myeloma Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Multiple Myeloma Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Multiple Myeloma Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Multiple Myeloma Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Multiple Myeloma Therapeutics Consumption Forecast (2022-2028)
9 Global Multiple Myeloma Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Multiple Myeloma Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy and Other Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiation Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Supportive Treatments Consumption and Growth Rate (2017-2022)
-
9.2 Global Multiple Myeloma Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Multiple Myeloma Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy and Other Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Supportive Treatments Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Multiple Myeloma Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Multiple Myeloma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Multiple Myeloma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Multiple Myeloma Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Multiple Myeloma Therapeutics Market Competitive Analysis
-
14.1 Bristol-Myers Squibb Company
-
14.1.1 Bristol-Myers Squibb Company Company Details
-
14.1.2 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Product and Service
-
14.3 Janssen Biotech Inc
-
14.3.1 Janssen Biotech Inc Company Details
-
14.3.2 Janssen Biotech Inc Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Janssen Biotech Inc Multiple Myeloma Therapeutics Product and Service
-
14.4 Millennium Pharmaceuticals
-
14.4.1 Janssen Biotech Inc Details
-
14.4.2 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product and Service
-
14.5 Celgene Corporation
-
14.5.1 Celgene Corporation Company Details
-
14.5.2 Celgene Corporation Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Celgene Corporation Multiple Myeloma Therapeutics Product and Service
-
14.6 Juno Therapeutics
-
14.6.1 Juno Therapeutics Company Details
-
14.6.2 Juno Therapeutics Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Juno Therapeutics Multiple Myeloma Therapeutics Product and Service
-
14.7 Kesios Therapeutics Limited
-
14.7.1 Kesios Therapeutics Limited Company Details
-
14.7.2 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product and Service
-
14.8 Amgene Inc
-
14.8.1 Amgene Inc Company Details
-
14.8.2 Amgene Inc Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Amgene Inc Multiple Myeloma Therapeutics Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Multiple Myeloma Therapeutics Product and Service
-
14.10 Genzyme Corporation
-
14.10.1 Genzyme Corporation Company Details
-
14.10.2 Genzyme Corporation Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Genzyme Corporation Multiple Myeloma Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Multiple Myeloma Therapeutics
-
Figure Multiple Myeloma Therapeutics Picture
-
Table Global Multiple Myeloma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple Myeloma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple Myeloma Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Multiple Myeloma Therapeutics Consumption by Country (2017-2022)
-
Figure United States Multiple Myeloma Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Multiple Myeloma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Multiple Myeloma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Multiple Myeloma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Multiple Myeloma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Multiple Myeloma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Myeloma Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Multiple Myeloma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy and Other Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Other Supportive Treatments Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy and Other Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Supportive Treatments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Multiple Myeloma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Multiple Myeloma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Multiple Myeloma Therapeutics Product and Service
-
Table Janssen Biotech Inc (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Inc Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Inc Multiple Myeloma Therapeutics Product and Service
-
Table Millennium Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Millennium Pharmaceuticals Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Multiple Myeloma Therapeutics Product and Service
-
Table Juno Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Juno Therapeutics Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics Multiple Myeloma Therapeutics Product and Service
-
Table Kesios Therapeutics Limited (Foundation Year, Company Profile and etc.)
-
Table Kesios Therapeutics Limited Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product and Service
-
Table Amgene Inc (Foundation Year, Company Profile and etc.)
-
Table Amgene Inc Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgene Inc Multiple Myeloma Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Multiple Myeloma Therapeutics Product and Service
-
Table Genzyme Corporation (Foundation Year, Company Profile and etc.)
-
Table Genzyme Corporation Multiple Myeloma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation Multiple Myeloma Therapeutics Product and Service
-
